Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2020-10-01 | 2020-11-07 | 125488 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-11-19 | 2021-01-21 | 128609 |
| TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-03-04 | 2021-11-18 | 135132 |
| TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-04-15 | 2021-11-18 | 137538 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-06-24 | 2022-02-05 | 141457 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2021-07-08 | 2021-09-02 | 142186 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-07-29 | 2022-02-05 | 143239 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2021-08-27 | 2021-09-16 | 144721 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-01-20 | 2022-03-09 | 153150 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2022-01-20 | 2023-07-14 | 153153 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2022-03-31 | 2022-08-19 | 157642 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-06-09 | 2022-08-20 | 162277 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2022-12-22 | 2023-12-14 | 179180 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-01-19 | 2023-01-26 | 181611 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-02-02 | 2023-07-14 | 183374 |
| TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-11-16 | 194068 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-10-04 | 194080 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-06-16 | 2023-07-06 | 195192 |
| TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-19 | 2023-07-05 | 195600 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195795 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |